40 studies found for:    " August 24, 2011":" September 23, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Enrolling by invitation Safety Study of Maraviroc's Effect on Human Osteoclasts
Conditions: HIV Infections;   AIDS
Intervention: Drug: Maraviroc
22 Active, not recruiting Screening for Tuberculosis in HIV-infected Patients Eligible for Antiretroviral Treatment
Conditions: HIV Infection;   Tuberculosis
Intervention:
23 Not yet recruiting Efficacy of Neuro-HAART in Patients With HIV
Condition: HIV
Intervention:
24 Recruiting Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS
Condition: HIV-1 Infection
Interventions: Drug: Coformulated EFV/FTC/TDF;   Drug: Etoposide;   Drug: Bleomycin and Vincristine (BV);   Drug: Doxorubicin HCL Liposome Injection (PLD)
25 Active, not recruiting Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate
Condition: HIV-1 Infection
Interventions: Drug: Niacin;   Drug: Aspirin;   Drug: Fenofibrate
26 Completed Cohort Field Study to Assess the Safety and Efficacy of the PrePex Device for Non-Surgical Circumcision When Performed by Nurses
Conditions: Male Circumcision;   HIV Prevention
Intervention: Device: PrePex™ device
27 Completed A Single Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Intramuscular and Subcutaneous Long Acting GSK1265744 in Healthy Subjects
Condition: Infections, Human Immunodeficiency Virus and Herpesviridae
Interventions: Drug: GSK1265744 injectable suspension;   Other: Placebo to match injectable suspension
28 Completed
Has Results
Potential for Drug-drug Interactions Between Boceprevir and Etravirine in HIV/Hepatitis C Virus Negative Volunteers
Conditions: Hepatitis C;   HIV
Intervention: Drug: boceprevir; etravirine
29 Active, not recruiting DRIVESHAFT: Darunavir/Ritonavir In HIV-infected Virologically-suppressed Experienced Subjects
Condition: HIV
Interventions: Drug: Twice-daily Darunavir/ritonavir;   Drug: Once-daily Darunavir/ritonavir
30 Completed A Key Link for Transmission Prevention
Condition: HIV
Interventions: Behavioral: Standard HIV prevention messages;   Behavioral: 5 counselor-delivered sessions;   Drug: ARVs with raltegravir and emtricitabine/tenofovir disoproxil fumarate
31 Completed The HJ MILE HIV Prevention Intervention for Post-incarcerated Men
Conditions: HIV;   Risk Reduction Behavior
Intervention: Behavioral: MILE intervention
32 Completed Comparative Tolerability of Protease Inhibitors
Condition: HIV
Intervention:
33 Completed The Effect of Intermittent Rifampicin on Raltegravir
Conditions: HIV;   Tuberculosis
Interventions: Drug: Raltegravir;   Drug: Rifampicin
34 Active, not recruiting AIMS Study: Improving HIV Treatment Adherence
Condition: HIV
Interventions: Behavioral: Usual care;   Behavioral: AIMS counseling
35 Active, not recruiting Improving Effective Contraceptive Use Among Opioid-maintained Women
Conditions: Contraceptive Usage;   Opioid Dependence
Interventions: Behavioral: Contraceptive management program;   Other: Usual care
36 Completed Evaluation of an Infant Feeding Intervention for HIV-exposed Haitian Infants
Condition: Lack of; Care, Infant (Child), Malnutrition
Intervention: Other: Counseling and nutrition supplement
37 Completed A South African Pilot Worksite Parenting Program to Prevent HIV Among Adolescents
Condition: Parent-Child Relations
Intervention: Behavioral: Let's Talk Worksite Parenting Program
38 Active, not recruiting Assessmet of Patients With PAH Right Ventricular Volume
Condition: Pulmonary Arterial Hypertension
Intervention: Device: Ventripoint Medical System
39 Completed Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB Disease
Condition: Tuberculosis
Interventions: Biological: GSK Biologicals' investigational TB vaccine GSK 692342;   Biological: Placebo
40 Active, not recruiting Immune Response and Safety Study of Human Papillomavirus (HPV) Vaccine in HIV-infected Pre-adolescent in Kenya
Conditions: Genital Warts;   Cervical Cancer
Intervention: Biological: Quadrivalent HPV Vaccine

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page
Indicates status has not been verified in more than two years